ROLE OF REPLICATION STRESS DURING MYC-DEPENDENT LYMPHOMAGENESIS

复制应激在 MYC 依赖性淋巴细胞生成过程中的作用

• 批准号: 7962386
• 负责人: David Dominguez-Sola
• 金额: $ 14.14万
• 依托单位: COLUMBIA UNIVERSITY HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-09-22 至 2012-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7962386
• 关键词: Address; Adoptive Transfer; Affect; B-Cell Lymphomas; B-Lymphocytes; Biological; Biological Assay; Biology; Cell Proliferation; Cells; Characteristics; DNA Damage; DNA biosynthesis; Development; Development Plans; Discipline; Disease; Engineering; Ensure; Environment; Epigenetic Process; Event; Gene Library; Genes; Genetic; Genetic Transcription; Goals; Growth; Hematopoietic stem cells; Human; In Vitro; Knowledge; Lesion; Lymphoma; Lymphomagenesis; Malignant Neoplasms; Measures; Mentors; Molecular; Mus; Mutagenesis; Oncogene Activation; Oncogenes; Oncogenic; Open Reading Frames; Outcome; Pathway interactions; Phase; Phenotype; Physiological; Process; Proteins; Proto-Oncogenes; Relative (related person); Replication Initiation; Reporter; Research; Research Project Grants; Role; Screening procedure; Stress; System; Systems Biology; Techniques; Testing; Tissues; Training; Transcriptional Regulation; Transgenic Mice; Validation; Variant; abstracting; base; c-myc Genes; cancer initiation; cancer therapy; cancer type; career development; cell transformation; coping; high throughput technology; in vivo; insight; interest; mouse model; mutant; neoplastic cell; new therapeutic target; novel; overexpression; public health relevance; response; skills; success; therapeutic target; tumor; tumor initiation; tumorigenesis; tumorigenic

DESCRIPTION (provided by applicant): Deregulated expression of the c-Myc protooncogene is a frequent requisite for the development of many human cancers. Despite extensive knowledge of its biology, we are still unaware of the precise molecular mechanisms that sustain its oncogenic activity. Amplification of the physiologic control of DNA replication initiation by Myc upon deregulation of its expression in primary cells and transgenic mouse B-cells causes replication stress and subsequent DNA damage. Replication stress is a phenomenon often seen in early cancers from different tissue origin, and it is believed to be consequent to oncogene activation. However, formal proof for its requirement during tumorigenesis is yet to be obtained. The long-term goal of this project is to characterize the contribution of Myc-dependent replication stress to B-cell lymphomagenesis. We will specifically assess whether altering Myc's ability to promote replication stress - by either ablating its ability to control DNA replication or modifying the cellular responses to Myc- dependent replication stress- determines the outcome of the oncogenic process. We hypothesize that pathways coping with replication stress restrain tumor initiation driven by this protooncogene and hence, manipulation of these pathways will determine Myc's ability to generate lymphomas when deregulated in B-cells. This Research Plan is meant to be part of a Career Development Plan through which I aim to obtain critical knowledge and technical skills on: (1) the application of mouse models to the study cancer initiation and progression; and (2) the use of high- throughput technologies and Systems Biology to address general questions in the cancer field that, due to their complexity, require integrated approaches. The extraordinary characteristics of the host center, where all these disciplines are integrated for the study of cancer, ensure an optimal environment for the training period. The mentored phase will therefore allow me to transit with success to an independent phase, where to continue to develop the final parts of this research project, obtain proof of principle for the above proposed research hypothesis, and pursue the study of the basic mechanisms of Myc-dependent B-cell lymphomagenesis, with aim to find novel therapeutic targets for this group of diseases. PUBLIC HEALTH RELEVANCE: Loss of normal control of Myc protein activity occurs in more than 70% of human cancers, and is essential for their initiation, growth and progression. This project proposes to examine the requirement during tumor development of a novel mechanism used by Myc to control cellular proliferation. Confirmation of this requirement will point to this function as a potential novel therapeutic target in a majority of cancer types.

描述（由申请人提供）：c-Myc原癌基因的表达失调是许多人类癌症发展的常见必要条件。尽管对其生物学有广泛的了解，但我们仍然不知道维持其致癌活性的精确分子机制。在原代细胞和转基因小鼠B细胞中Myc表达失调时，Myc对DNA复制起始的生理控制的扩增引起复制应激和随后的DNA损伤。复制应激是一种常见于不同组织来源的早期癌症的现象，并且被认为是癌基因激活的结果。然而，在肿瘤发生过程中需要它的正式证据尚未获得。该项目的长期目标是描述Myc依赖性复制应激对B细胞淋巴瘤发生的贡献。我们将具体评估是否改变Myc促进复制应激的能力-通过消除其控制DNA复制的能力或改变细胞对Myc依赖性复制应激的反应-决定致癌过程的结果。我们假设，应对复制应激的途径抑制了由该原癌基因驱动的肿瘤起始，因此，这些途径的操纵将决定Myc在B细胞中失调时产生淋巴瘤的能力。 本研究计划是职业发展计划的一部分，通过该计划，我的目标是获得以下方面的关键知识和技术技能：（1）将小鼠模型应用于研究癌症的启动和进展;以及（2）使用高通量技术和系统生物学来解决癌症领域的一般问题，由于其复杂性，需要综合方法。主办中心的非凡特点，其中所有这些学科都集成了癌症的研究，确保了培训期间的最佳环境。因此，指导阶段将使我成功过渡到一个独立的阶段，在那里继续开发本研究项目的最后部分，为上述提出的研究假设获得原理证明，并继续研究Myc依赖性B细胞淋巴瘤发生的基本机制，旨在为这组疾病找到新的治疗靶点。 公共卫生关系：超过70%的人类癌症发生Myc蛋白活性正常控制的丧失，并且对于它们的起始、生长和进展是必不可少的。该项目旨在研究Myc用于控制细胞增殖的新机制在肿瘤发展过程中的需求。这一要求的确认将指出这种功能在大多数癌症类型中是一种潜在的新型治疗靶点。